Tatiana K Bronich Selected Research

Tatiana K Bronich Research Topics

Disease

22	Neoplasms (Cancer) 10/2021 - 01/2009
7	Ovarian Neoplasms (Ovarian Cancer) 12/2015 - 08/2011
4	Breast Neoplasms (Breast Cancer) 01/2019 - 06/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 01/2019
3	Carcinoma (Carcinomatosis) 04/2010 - 08/2006
2	Lupus Nephritis 10/2020 - 01/2018
2	Nephritis 10/2020 - 01/2018
2	Infections 01/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012 - 11/2007
1	Neuroblastoma 11/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2019
1	Adenocarcinoma 01/2019
1	Multiple Myeloma 01/2019
1	Disease Progression 01/2019
1	Carcinogenesis 01/2019
1	Atrophy 01/2018
1	Metabolic Bone Diseases (Osteopenia) 01/2018
1	Proteinuria 01/2018
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2014
1	Coinfection 05/2013
1	Brain Injuries (Brain Injury) 09/2012
1	Parkinson Disease (Parkinson's Disease) 09/2007

Drug/Important Bio-Agent (IBA)

15	Pharmaceutical PreparationsIBA 10/2021 - 01/2009
12	MicellesIBA 10/2021 - 08/2006
6	NanogelsIBA 12/2015 - 03/2011
5	Cisplatin (Platino)FDA LinkGeneric 12/2015 - 08/2006
4	Peptides (Polypeptides)IBA 10/2017 - 05/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016 - 06/2012
4	PolymersIBA 11/2013 - 01/2009
3	polyethylene glycol polyethyleneimine nanogelIBA 01/2019 - 10/2013
3	Drug CombinationsIBA 01/2019 - 11/2013
3	PlatinumIBA 01/2019 - 11/2013
3	AntioxidantsIBA 09/2012 - 09/2007
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2021 - 01/2012
2	LigandsIBA 11/2020 - 12/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2020 - 01/2018
2	ProdrugsIBA 10/2020 - 01/2018
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2015 - 08/2011
2	Ethylene Glycol (Monoethylene Glycol)IBA 12/2015 - 01/2012
2	methacrylic acidIBA 01/2012 - 02/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2021
1	folfirinoxIBA 10/2021
1	BuffersIBA 11/2020
1	Chemotactic FactorsIBA 11/2020
1	AlginatesIBA 11/2020
1	CytokinesIBA 11/2020
1	ChemokinesIBA 11/2020
1	hydroxypropyl methacrylateIBA 10/2020
1	Superoxides (Superoxide)IBA 01/2020
1	Superoxide DismutaseIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	PorphyrinsIBA 01/2020
1	ManganeseIBA 01/2020
1	SP1017IBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	AntigensIBA 01/2019
1	Surface-Active Agents (Surfactants)IBA 01/2019
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2019
1	Proteasome InhibitorsIBA 01/2019
1	GlucocorticoidsIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	dexamethasone 21-phosphate FDA LinkGeneric 01/2018
1	Trastuzumab (Herceptin)FDA Link 03/2016
1	Monoclonal AntibodiesIBA 03/2016
1	Cell Surface ReceptorsIBA 03/2016
1	Ado-Trastuzumab EmtansineIBA 03/2016
1	Phenylalanine (L-Phenylalanine)FDA Link 12/2015
1	Glutamic Acid (Glutamate)FDA Link 12/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2015
1	taxaneIBA 12/2015
1	tanespimycin (17AAG)IBA 06/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2014
1	AlbuminsIBA 01/2014
1	Therapeutic UsesIBA 11/2013
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 10/2013
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2013
1	Poloxamer (Poloxamer 407)IBA 05/2013
1	Liposomes (Liposome)IBA 05/2013
1	Antiviral Agents (Antivirals)IBA 05/2013
1	imidazole mustard (BIC)IBA 06/2012
1	EnzymesIBA 01/2012
1	PolyelectrolytesIBA 08/2011
1	Biological ProductsIBA 08/2011
1	Glycoproteins (Glycoprotein)IBA 03/2011
1	AldehydesIBA 03/2011
1	DisulfidesIBA 04/2010
1	Ethylene Oxide (Oxirane)IBA 02/2010
1	Coat Protein Complex I (COPI)IBA 11/2007

Therapy/Procedure

9	Therapeutics 11/2020 - 08/2011
4	Drug Therapy (Chemotherapy) 11/2013 - 02/2010
1	Immunotherapy 11/2020
1	Radiotherapy 01/2019
1	Laser Therapy (Surgery, Laser) 01/2018
1	Intravenous Administration 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 11/2013